BioSpace News Archive

Jardiance® (empagliflozin) 10 mg has been approved by the U.S. Food and Drug Administration to reduce the risk of cardiovascular death plus hospitalization for heart failure in adults with heart failure with reduced ejection fraction (HFrEF), Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced today.

American Bio Medica Corporation (OTCQB:ABMC) today announced financial results for the three and six months ended June 30, 2021.

MicroConstants, Inc., a leader in bioanalytical testing services, announced that it has signed an agreement with BioAgilytix Labs, a leading global contract research organization (CRO) focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development.

BIOASIS TECHNOLOGIES INC . today announced the appointment of Shadow Lake Group Inc. and its affiliate SLG Europe BV (“SLG”) as Business Development advisor.

Paratek Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted the company orphan drug designation for NUZYRA ® (omadacycline) for the treatment of infections caused by Nontuberculous Mycobacteria (NTM).

Illumina, Inc. (NASDAQ: ILMN) announced today that it has acquired GRAIL, a healthcare company focused on life-saving early detection of multiple cancers using Galleri test.

Glaucoma Research Foundation (GRF), the nation’s oldest and largest non-profit organization dedicated to funding research to find a cure for glaucoma, today announced the receipt of a $1.5 million matching gift from Steve and Michele Kirsch of Palo Alto, California.

Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced positive interim results from the pivotal study “CHOICE-01” (NCT03856411), a randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating toripalimab plus chemotherapy as first-line treatment of advanced squamous or non-squamous non-small cell lung cancer (NSCLC).

The upper extremity is defined as the section of the body from the fingers’ tips to the arm, continuing towards the spine.

Diabetes Research Connection, a 501 that connects early-career scientists and donors to fund research projects aimed at prevention, cure, and better care for those with T1 Diabetes, is accepting letters of intent through August 31 for research grants ranging from $25,000 - $50,000.